Scripps launches digital clinical trial to test repurposed drug for Long COVID
- Condition
- Long COVID
- At worst
- Very severe (bedbound, unable to do basic care)
- Ill for
- 1 year
- Published
- Oct 2025
Summary
Credits GLP 1. An unnamed patient was ill 1y with very-severe long COVID and reports a substantial improvement. Poster's daughter, bedridden a year, thriving days after Ozempic.
This summary was assembled from the coded record rather than written from a full reading of the page, so it is short. The original has the detail.
What they credit
Credits GLP-1 drugs (semaglutide, tirzepatide).
Similar stories
-
Experimental peptides are being advertised for Long COVID (Joshua)
Joshua began microdosing tirzepatide about six months before the article was written, though no specific dose is given. The article does not describe how long he had been sick or how severe his Long COVID was, but he reported that within hours of his first…
-
ME/CFS patient substantially improved with spironolactone 100 mg daily
Poster combined spironolactone 25mg/day with LDN, a GLP-1 agonist and NP thyroid and states plainly "My CFS is cured, yes cured...my health is amazing," while noting he still needs cortisol supplementation. Because several drugs were changed together it is…